Clinical trial
SU5416 and Paclitaxel in Treating Patients With Advanced Cancer
NCT00006257 · City of Hope Medical Center, Other · Completed
Key facts
| NCT number | NCT00006257 |
|---|---|
| Title | SU5416 and Paclitaxel in Treating Patients With Advanced Cancer |
| Official title | Phase I Trial of SU5416 in Combination With Weekly Paclitaxel in Patients With Advanced Malignancies |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | paclitaxel, semaxanib |
| Start date | Nov 1, 2000 |
| First posted | Oct 8, 2003 |
| Last update posted | Jan 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: